Paul's a MUPPET |
PAUL IS ON SYME promoting that & asking DUM QUESTIONS OF WHY IS IT DOWN LOOOOOOOOOOOL LIKE SYME THE BIGGEST BOILER ROOM FRAUD SCAM THERE IS HOW THAT SHARE IS EVEN STILL ON IS BEYOND ME THE AIM MARKET IS BEYOND CORRUPT NOW WOULD YOU LISTEN TO A MAN WHO IS AKSING OTHERS WHY SYME IS DOWN !! Take a minute to think about that one LOOOL |
Please don't loose any more money into this junk PURE JUNK |
The guy below me is the main leader of the gang his paid 30p per post |
STOP LYING NO TAKE OVER PEOPLE THESE ARE BOILER ROOM SCUM IGNORE THEM IL EXPLAIN IF YOU GOOGLE A "stock boiler room" you will see what these people do Now use your brain this is about to CRASH they have had terrible results & a new law suit case opened how will they win ? There is 200,568 new cases of claims being filed as we speak this is going to TANK GOOD LUCK HOLDING A FALLING KNIFE !!!!Please don't be fooled people take action now while you can |
Consumer disposable income crises everybody is thinking twice about what they buy and how much they spend. |
PPE: I wish I was like you Paul, I alas always buy the same packet that worked for me before. |
Generic drugs are much cheaper and have virtually the same ingredients as branded products. Why pay £3.50 for panadol when the same drug can be acquired for 49p. Consumers will look for value and not pay for expensive and environmentally unfriendly glossy packaging when the product inside is the exact same thing selling for a fraction of the price just check the ingredients to validate. |
With so many viruses around this Winter, there is clearly ONE BIG winner -
over-the-counter drug companies that sell stuff for sore throats and runny noses.
(headaches too). |
Firm again in NY. 328. |
Slowly but surely this is marching up.. |
Lots of colds and flu.
Could be good for sales. |
Looking good again today!! |
With the shares back above £3 will we see some selling from Pfizer or GSK soon? |
As I've been saying, it was a bargain a few months ago and still a bargain at current prices. |
That wasn't the attitude taken by GSK when news of the action first broke! |
Haleon - Barclays raises target price to 360p from 298p, overweight. |
Added rather than got in but thanks. I think the first day's close was around 335. It was noted somewhere earlier on the thread. |
PatientCapital, I think that was a day range but didn't close at those levels.Glad that you got in at the 250s levels. |
HLN was never impacted by Zantac so nice rise |
The point is did Zantac cause cancer or not. Given the sheer number of claims there were bound to be some that just jumped on the bandwagon. The point is how many are genuine.
All the drugmakers have denied that Zantac causes cancer.
Zantac, first approved in 1983, became the world's best selling medicine in 1988 and one of the first-ever drugs to top $1 billion in annual sales. Originally marketed by a forerunner of GSK, it was later sold successively to Pfizer, Boehringer Ingelheim and finally Sanofi. |
No it was nearer 3.40/50 post demerger. Happy to have added in the 2.50s during the turmoil. |
All time high? |
Register to chat with like-minded investors on our interactive forums.
Hot Features
Premium
